DFP-14927 is under clinical development by Delta-Fly Pharma and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase II drugs for Refractory Acute Myeloid ...

DFP-14927 is under clinical development by Delta-Fly Pharma and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I drugs for Pancreatic Cancer have a 74% phase transition ...

Aa A A Aaaaaa Aa 43.85 +23.89% ...

1 Day 4598 0.19% DJIA 0.86% S&P 500 0.16% Health Care/Life Sciences 0.43% ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, covering its ET-600 product candidate’s proprietary ...

Merck & Co. Inc.-0.13% $250.31B ...

Conduit Pharmaceuticals (CDT) announces the successful completion of all milestones in Phase I of its strategic collaboration with Sarborg Limited. This transition to Phase II marks a positive ...

After hours: February 7 at 4:20:01 PM EST Loading Chart for LGND ...

Commissions do not affect our editors' opinions or evaluations. The best credit cards for Delta SkyMiles can offer frequent flyers valuable travel benefits, like bonus miles, lounge access ...